Scarica l'app Stockscreener
78.18
0.95%
-0.75
Dopo l'orario di chiusura:
77.30
-0.88
-1.13%
Precedente Chiudi:
$78.93
Aprire:
$78.11
Volume 24 ore:
425.88K
Relative Volume:
0.61
Capitalizzazione di mercato:
$4.31B
Reddito:
$1.43B
Utile/perdita netta:
$107.13M
Rapporto P/E:
40.36
EPS:
1.9372
Flusso di cassa netto:
$161.04M
1 W Prestazione:
-3.72%
1M Prestazione:
+2.22%
6M Prestazione:
+26.24%
1 anno Prestazione:
+38.32%
Intervallo 1D:
$77.37
$78.88
Intervallo di 1 settimana:
$77.37
$82.22
Portata 52W:
$48.82
$85.76
Livanova Plc Stock (LIVN) Company Profile
Nome
Livanova Plc
Settore
Industria
Telefono
4402033250662
Indirizzo
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
78.18 | 4.35B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-20 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Iniziato | Goldman | Buy |
| 2024-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Reiterato | Needham | Buy |
| 2024-02-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-04-14 | Iniziato | Mizuho | Neutral |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-02-24 | Aggiornamento | UBS | Neutral → Buy |
| 2021-12-03 | Iniziato | Goldman | Buy |
| 2021-08-20 | Reiterato | Needham | Buy |
| 2021-07-20 | Aggiornamento | Needham | Hold → Buy |
| 2021-03-03 | Downgrade | Berenberg | Buy → Hold |
| 2021-01-05 | Downgrade | Needham | Buy → Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-06-26 | Reiterato | Needham | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-08 | Iniziato | Stifel | Buy |
| 2018-05-31 | Reiterato | Needham | Buy |
| 2018-02-28 | Reiterato | Needham | Buy |
Mostra tutto
Livanova Plc Borsa (LIVN) Ultime notizie
LivaNova Director Sells 1,650 Shares for $131,500 - The Motley Fool
LivaNova (NASDAQ: LIVN) officer plans 3,500-share sale from 2026 stock award vesting - stocktitan.net
LivaNova PLC (NASDAQ:LIVN) Combines Strong Growth With a Timely Technical Setup - ChartMill
Director at LivaNova (NASDAQ: LIVN) sells 2,300 shares - stocktitan.net
LivaNova (NASDAQ:LIVN) Combines Growth and Reasonable Valuation - ChartMill
LivaNova (NASDAQ: LIVN) executive plans stock sale - stocktitan.net
LivaNova (LIVN) Declines 1.5% to $81.13 Amid Medical Device Sector CautionDiagonal Spread Trade - vinanet.vn
LivaNova (LIVN) Director Francesco Bianchi Sells 1,650 Shares - GuruFocus
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September - Yahoo Finance
LivaNova stock gains as Piper Sandler raises price target on strong Q2 results - ad-hoc-news.de
LivaNova (NASDAQ: LIVN) officer lines up six-figure stock sale - stocktitan.net
LivaNova PLC (LIVN) director sells 1,650 shares - stocktitan.net
LIVN Reiterated by Piper Sandler -- Price Target Raised to $90 - GuruFocus
Piper Sandler raises Livanova stock price target on cardiopulmonary growth outlook - Investing.com
LivaNova stock holds near 80 USD as investors digest latest earnings and ownership shift - ad-hoc-news.de
(LIVN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
LivaNova (NASDAQ: LIVN) officer to sell 1,650 shares - Stock Titan
LivaNova: Quantitative Stock of the Week - Barron's
Is LivaNova (LIVN) Fairly Valued As Growth Hopes Meet Reimbursement Risks? - Sahm
LivaNova: Careful About The Valuation And Upside (NASDAQ:LIVN) - Seeking Alpha
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionEarnings Manipulation Risk - vinanet.vn
LIVN Looks 23.4% Overvalued on GF Value™ - GuruFocus
LivaNova (NASDAQ:LIVN) Downgraded by Zacks Research to "Hold" - MarketBeat
LivaNova PLC (LIVN) Stock Down 3.3% but Still Overvalued -- GF S - GuruFocus
Anne Liddy Joins LivaNova as Chief Legal Officer - Medical Product Outsourcing
LivaNova (NASDAQ:LIVN) Gains Attention After Strong Results - Kalkine Media
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseCall Wall - dars.gov.et
LivaNova (LIVN) Reported Quarter: Profit Per Share Surpasses Its Benchmark at the Close; Share-Price Check: Shares Move 1.57% Lower in the Available RecordAnalyst Consensus Shift - dars.gov.et
LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setup - ChartMill
LivaNova (LIVN) Q2 2026 Earnings Call Transcript - AOL.com
LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DE - MarketBeat
Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stock - Benzinga
LivaNova CIO Ahmet Tezel Reports Stock Transactions and Ownership Update - Kalkine Media
LivaNova PLC (LIVN) Stock forecasts - Yahoo Finance UK
LivaNova (LIVN) executive exercises 12,692 SARs and disposes shares - Stock Titan
Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN) - Yahoo Finance
LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance - Yahoo Finance
LivaNova PLC (LIVN) employee stock rights lead to 2,675-share sale - Stock Titan
LivaNova PLC (LIVN) Stock Forecasts - Yahoo! Finance Canada
LivaNova (LIVN) Is Down 7.6% After Swinging Back To Profitability In Q2 2026What's Changed - webull.com
LivaNova Plans for Early 2027 Launch of Aura6000 for Obstructive Sleep Apnea - Morningstar
LivaNova PLC at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Q3 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
Q1 2026 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC $LIVN Shares Purchased by Quantinno Capital Management LP - MarketBeat
Price to earnings forward of LivaNova Plc – FWB:LIA - TradingView
LivaNova revenue increases 10.8% in Q2 2026 - medicalbuyer.co.in
LivaNova PLC (LIVN) Stock News Today - TradingKey
LivaNova PLC (LIA) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
LivaNova PLC (LIA) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Livanova Plc Azioni (LIVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.29%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):